Background
Longitudinal whole-population studies can explore new dimensions in drug
allergy research. Excipient allergy testing remains a barrier to allergy
evaluation in countries without legislations mandating ingredient
disclosure in registered drugs. The Comprehensive Excipient and Drug
Allergy Registry (CEDAR) was established to investigate Hong Kong’s drug
allergy landscape and potential role of excipient registries.